Clinical Characteristics of Patients with Ventricular Fibrillation during Antiarrhythmic Drug Therapy
- 4 August 1988
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 319 (5) , 257-262
- https://doi.org/10.1056/nejm198808043190501
Abstract
We retrospectively studied 28 patients with 38 episodes of newly occurring ventricular fibrillation during antiarrhythmic drug therapy. Twenty-six of these patients, who had ventricular fibrillation during single-drug therapy with quinidine, procainamide, or disopyramide, were compared with a control group of 62 patients who had been treated similarly for ventricular arrhythmias but did not have ventricular fibrillation during treatment.This publication has 28 references indexed in Scilit:
- Polymorphic ventricular tachycardia and ventricular fibrillation due to N-acetyl procainamideThe American Journal of Cardiology, 1985
- Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogramThe American Journal of Cardiology, 1984
- Antiarrhythmic Drugs: a Possible Cause of Out-of-Hospital Cardiac ArrestNew England Journal of Medicine, 1983
- Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillationAmerican Heart Journal, 1983
- Amiodarone-induced polymorphous ventricular tachycardiaAmerican Heart Journal, 1983
- Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: Identification of drugs that exacerbate tachycardia and potential mechanismsAmerican Heart Journal, 1982
- Tocainide-induced ventricular fibrillationAmerican Heart Journal, 1981
- Disopyramide-induced ventricular fibrillationThe American Journal of Cardiology, 1979
- Quinidine SyncopeCirculation, 1964
- A CLINICAL REPORT ON THE USE OF QUINIDIN SULPHATEArchives of internal medicine (1960), 1923